Canary Capital submitted a preliminary filing on Sept. 24 for an Injective (INJ) ETF that plans to stake at least 90% of its INJ tokens to earn rewards. The fund's daily net asset value will reflect staking rewards, but no cash rewards will be paid to shareholders. Staking fees, which will be shared among the provider, sponsor, and custodian, have not been specified yet. The filing is still preliminary, so shares cannot be sold until it becomes effective, and rewards are not guaranteed due to market price fluctuations and the 21-day unbonding period for tokens.
Injective (INJ) tokens are currently trading at Rp148.222 on Pluang, showing a 0.76% decline in the past day. The market cap stands at Rp14,87 trillion with a 24-hour trading volume of Rp2,1 trillion. As of Oct 23, 2026 11:21 WIB, sell orders dominate at 90%, and the typical hold time is 38 days.
Among the 90 largest cryptocurrencies, MemeCore (M) surged 17.03% in 24 hours, leading gains while 72 out of 90 assets declined. Other notable risers included Lighter (8.54%), Monero (5.85%), and Bitway (5.53%). Conversely, LayerZero fell the most by...
Injective (INJ) traded below the key $8.90 level on October 22, falling 7% within 24 hours. This dip puts into question a previous bullish technical scenario that required daily closes above $8.90 to remain valid. While the intraday price dropped bel...
Canary Capital proposes an Injective (INJ) ETF that reinvests staking rewards back into the fund rather than distributing cash to shareholders. The fund delegates tokens to validators on the Injective network, with staking rewards paid in INJ tokens....
The price of Injective's native token, INJ, fell 7% to $8.15 in a 24-hour period ending October 22. This decline was captured in a specific market snapshot and does not indicate the cause of the drop. Injective operates a monthly Community BuyBack pr...
A projection based on trendline analysis suggests Injective (INJ) might reach $100 around 2029, contingent on breaking and retesting the $50–$53 resistance zone. Increased active addresses and developer activity support the token's potential but do n...
